Business Wire
-
StatLab Launches PiSmart S1 Slide Printer, And Expands U.S. Manufacturing In Arlington
9/17/2025
StatLab Medical Products, a leading global developer and manufacturer of pathology supplies and equipment, today announced the global launch of the PiSmart S1 single-hopper slide printer, expanding its existing PiSmart labeling and tracking solutions of both slide and cassette printers.
-
Genesee Scientific Acquires Jade Scientific, Expanding Capabilities In Lab Essentials Market
9/15/2025
Genesee Scientific, a leading provider of high-quality, value-driven lab essentials, today announced the acquisition of Jade Scientific, a Michigan-based distributor recognized for its extensive offering of chemicals and consumables to clinical reference, pharma/biotech, and environmental labs nationwide.
-
OmniPathology And Delta Labs Announce International Collaboration To Expand Access To Proprietary Oropharyngeal HPV Swab Testing
9/15/2025
OmniPathology, a U.S.-based advanced molecular diagnostics laboratory, today announced a new international collaboration with Delta Medical Laboratories, a leading clinical laboratory provider in Saudi Arabia.
-
QIAGEN Secures European CE-IVDR Certification For Full QIAstat-Dx Portfolio
9/10/2025
QIAGEN today announced that it has achieved CE-IVDR certification for its full portfolio of QIAstat-Dx syndromic testing systems and panels, including an expanded Meningitis/Encephalitis (ME) Panel that sets a new benchmark in the diagnosis of central nervous system (CNS) infections.
-
Exact Sciences Launches Cancerguard™, First-Of-Its-Kind Multi-Cancer Early Detection Blood Test
9/10/2025
Exact Sciences Corp. a leader in cancer diagnostics, today announced the launch of the Cancerguard test, a new multi-cancer early detection (MCED) blood test that is now available as a laboratory-developed test (LDT) in the United States.
-
Sapio Sciences And Ultima Genomics Partner To Advance Multi-Omics Research
9/9/2025
Sapio Sciences, the science-aware lab informatics platform, today announced a strategic partnership with Ultima Genomics.
-
Arima Genomics Introduces Aventa Lymphoma Test To Resolve Diagnostic Uncertainty In B- And T-Cell Lymphomas
9/3/2025
Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced the broad commercial launch of the Aventa Lymphoma test at the Society of Hematologic Oncology (SOHO 2025) meeting in Houston, Texas.
-
QIAGEN Gains U.S. Clearance Of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access To Rapid Syndromic Testing
9/2/2025
QIAGEN N.V. today announced the launch of QIAstat‑Dx Rise – a version of the QIAstat-Dx automated syndromic testing system that offers unparalled throughput with the easiest workflow available to customers worldwide.
-
SeqOne Acquires Congenica To Create A Global Leader In AI-Powered Genomic Medicine
9/2/2025
SeqOne, a pioneer in AI-driven genomic analysis, today announced it has entered into a definitive agreement to acquire Congenica, the UK company spun out of the prestigious Wellcome Sanger Institute.
-
WMI Partners With Arcadea Group
8/26/2025
Arcadea Group, a preeminent, long-term investor in global software businesses, today announced its acquisition of WMI, a leading provider of laboratory information management solutions in Brazil through its flagship Autolac software suite.